- Home
- DSP vs SGMO Comparison
DSP vs SGMO Comparison
Compare DSP & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSP | SGMO |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.3M | 155.1M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DSP | SGMO |
|---|---|---|
| Price | $11.72 | $0.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $18.50 | $4.71 |
| AVG Volume (30 Days) | 261.6K | ★ 9.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.49 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $324,131,000.00 | $32,875,000.00 |
| Revenue This Year | $17.79 | $1.37 |
| Revenue Next Year | $17.72 | N/A |
| P/E Ratio | $120.95 | ★ N/A |
| Revenue Growth | ★ 22.97 | N/A |
| 52 Week Low | $8.11 | $0.38 |
| 52 Week High | $26.33 | $2.82 |
Technical Indicators
Market Signals| Indicator | DSP | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 42.75 |
| Support Level | $11.10 | $0.43 |
| Resistance Level | $12.26 | $0.46 |
| Average True Range (ATR) | 0.50 | 0.03 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 56.45 | 15.84 |
Price Performance
Historical ComparisonAbout DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.